Barriers to enrollment in a randomized controlled trial of hydrocortisone for cardiovascular insufficiency in term and late preterm newborn infants

OBJECTIVE: To analyze reasons for low enrollment in an RCT of the effect of hydrocortisone for cardiovascular insufficiency on survival without neurodevelopmental impairment (NDI) in term/late-preterm newborns. STUDY DESIGN: The original study was a multicenter RCT. Eligibility: ≥34 weeks’ gestation...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Perinatol
Egile Nagusiak: Watterberg, Kristi L., Fernandez, Erika, Walsh, Michele C., Truog, William E., Stoll, Barbara J., Sokol, Gregory M., Kennedy, Kathleen A., Fraga, Maria V., Beauman, Sandra Sundquist, Carper, Benjamin, Das, Abhik, Duncan, Andrea Freeman, Buss, William F., Gauldin, Cheri, Lacy, Conra Backstrom, Sanchez, Pablo J., Chawla, Sanjay, Lakshminrusimha, Satyan, Cotten, C. Michael, Van Meurs, Krisa P., Poindexter, Brenda B., Bell, Edward F., Carlo, Waldemar A., Devaskar, Uday, Wyckoff, Myra H., Higgins, Rosemary D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5688018/
https://ncbi.nlm.nih.gov/pubmed/28880260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jp.2017.131
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak